Johnson & Johnson (JNJ) Beats
The market needed Johnson & Johnson (JNJ) to come though with big numbers to show that the consumer goods and medical devices markets, which to a large extent depend on consumer healthcare, were OK. JNJ delivered better than expected. Johnson…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The market needed Johnson & Johnson (JNJ) to come though with big numbers to show that the consumer goods and medical devices markets, which to a large extent depend on consumer healthcare, were OK.
JNJ delivered better than expected.
Johnson & Johnson announced sales of $15.9 billion for the third quarter of 2008, an increase of 6.4% as compared to the third quarter of 2007.
Net earnings and diluted earnings per share for the third quarter of 2008 were $3.3 billion and $1.17, respectively, up over 10%.
Douglas A. McIntyre.
Contact [email protected] for any questions or corrections.


